Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
NCT ID: NCT00481039
Last Updated: 2009-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2007-05-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sickle Cell Anemia Screening and Prevention in Northern Israel
NCT00735488
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
NCT01905787
Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous
NCT00481260
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients diagnosed as having abnormal hemoglobin like hemoglobin S and thalassemia in a bedouin village
Medical history and basic laboratory analysis
Medical history and basic laboratory analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical history and basic laboratory analysis
Medical history and basic laboratory analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pediatric Hematology Unit - Ha'Emek Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ariel Koren, MD
Role: STUDY_DIRECTOR
Pediatric Hematology Unit, Ha'Emek Medical Center
luci Zalman, Phd
Role: STUDY_CHAIR
Hematology Laboratory - HaEmek Medical Center
Tania Flaishman, Student
Role: PRINCIPAL_INVESTIGATOR
Pediatric Dpt B - Ha'Emek Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Hematology Unit - HaEmek Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5311006.EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.